These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 16894398

  • 1. Tacrolimus: focusing on atopic dermatitis.
    Carroll CL, Fleischer AB.
    Drugs Today (Barc); 2006 Jul; 42(7):431-9. PubMed ID: 16894398
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.
    Breuer K, Werfel T, Kapp A.
    Am J Clin Dermatol; 2005 Jul; 6(2):65-77. PubMed ID: 15799678
    [Abstract] [Full Text] [Related]

  • 3. Tacrolimus ointment for the treatment of atopic dermatitis: clinical and pharmacologic effects.
    Rico MJ, Lawrence I.
    Allergy Asthma Proc; 2002 Jul; 23(3):191-7. PubMed ID: 12125507
    [Abstract] [Full Text] [Related]

  • 4. Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: a meta-analysis of randomized clinical trials.
    Chen SL, Yan J, Wang FS.
    J Dermatolog Treat; 2010 May; 21(3):144-56. PubMed ID: 20394490
    [Abstract] [Full Text] [Related]

  • 5. An approach to pruritus in atopic dermatitis: a critical systematic review of the tacrolimus ointment literature.
    Fleischer AB, Boguniewicz M.
    J Drugs Dermatol; 2010 May; 9(5):488-98. PubMed ID: 20480792
    [Abstract] [Full Text] [Related]

  • 6. Calcineurin inhibitors in pediatric atopic dermatitis: a review of current evidence.
    Kalavala M, Dohil MA.
    Am J Clin Dermatol; 2011 Feb 01; 12(1):15-24. PubMed ID: 21067248
    [Abstract] [Full Text] [Related]

  • 7. [New immune suppressants: topical immunomodulatory agents].
    Senatorski G, Sułowicz W, Paczek L.
    Przegl Lek; 2002 Feb 01; 59(11):907-11. PubMed ID: 12715720
    [Abstract] [Full Text] [Related]

  • 8. Pimecrolimus in dermatology: atopic dermatitis and beyond.
    Gisondi P, Ellis CN, Girolomoni G.
    Int J Clin Pract; 2005 Aug 01; 59(8):969-74. PubMed ID: 16033622
    [Abstract] [Full Text] [Related]

  • 9. The role of topical calcineurin inhibitors in atopic dermatitis.
    Alomar A, Berth-Jones J, Bos JD, Giannetti A, Reitamo S, Ruzicka T, Stalder JF, Thestrup-Pedersen K, European Working Group on Atopic Dermatitis.
    Br J Dermatol; 2004 Dec 01; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
    [Abstract] [Full Text] [Related]

  • 10. Tacrolimus ointment: a review of its use in atopic dermatitis and its clinical potential in other inflammatory skin conditions.
    Simpson D, Noble S.
    Drugs; 2005 Dec 01; 65(6):827-58. PubMed ID: 15819596
    [Abstract] [Full Text] [Related]

  • 11. Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis.
    Cheer SM, Plosker GL.
    Am J Clin Dermatol; 2001 Dec 01; 2(6):389-406. PubMed ID: 11770393
    [Abstract] [Full Text] [Related]

  • 12. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children.
    Remitz A, Harper J, Rustin M, Goldschmidt WF, Palatsi R, van der Valk PG, Sharpe G, Smith CH, Dobozy A, Turjanmaa K, European Tacrolimus Ointment Study Group.
    Acta Derm Venereol; 2007 Dec 01; 87(1):54-61. PubMed ID: 17225017
    [Abstract] [Full Text] [Related]

  • 13. Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.
    Hultsch T, Kapp A, Spergel J.
    Dermatology; 2005 Dec 01; 211(2):174-87. PubMed ID: 16088174
    [Abstract] [Full Text] [Related]

  • 14. Pimecrolimus cream and Tacrolimus ointment in the treatment of atopic dermatitis: a pilot study on patient preference.
    Onumah N, Kircik L.
    J Drugs Dermatol; 2013 Oct 01; 12(10):1145-8. PubMed ID: 24085050
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the efficacy and safety of 0.1% tacrolimus ointment with topical corticosteroids in adult patients with atopic dermatitis: review of randomised, double-blind clinical studies conducted in Japan.
    Nakagawa H.
    Clin Drug Investig; 2006 Oct 01; 26(5):235-46. PubMed ID: 17163257
    [Abstract] [Full Text] [Related]

  • 16. Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis.
    Frankel HC, Qureshi AA.
    Am J Clin Dermatol; 2012 Apr 01; 13(2):113-23. PubMed ID: 22263704
    [Abstract] [Full Text] [Related]

  • 17. Safety and efficacy of tacrolimus ointment versus pimecrolimus cream in the treatment of patients with atopic dermatitis previously treated with corticosteroids.
    Kirsner RS, Heffernan MP, Antaya R.
    Acta Derm Venereol; 2010 Apr 01; 90(1):58-64. PubMed ID: 20107727
    [Abstract] [Full Text] [Related]

  • 18. Tacrolimus ointment: a new therapy for atopic dermatitis--review of the literature.
    Pustisek N, Lipozencić J, Ljubojević S.
    Acta Dermatovenerol Croat; 2002 Mar 01; 10(1):25-32. PubMed ID: 12137728
    [Abstract] [Full Text] [Related]

  • 19. Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis.
    Nghiem P, Pearson G, Langley RG.
    J Am Acad Dermatol; 2002 Feb 01; 46(2):228-41. PubMed ID: 11807435
    [Abstract] [Full Text] [Related]

  • 20. Topical calcineurin inhibitors in atopic dermatitis: a systematic review and meta-analysis.
    El-Batawy MM, Bosseila MA, Mashaly HM, Hafez VS.
    J Dermatol Sci; 2009 May 01; 54(2):76-87. PubMed ID: 19303745
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.